stocksbrew

Bristol-Myers Squibb CompanyBMY

Buy more

Buy more on a dip to our buy price, which is under today's $63.

  • 7 good· Earnings beat
  • 3 to watch· Insider selling

$62.53−0.38 (−0.60%)

Price at 3:01 PM ET

After hours · opens in 17h 23mNext open: Friday, Nov 13, 9:30 AM ET

NYSE · Healthcare · Pharmaceuticals · Large company

The price we'd buy BMY at comes with a free account

It also has the whole brief, the scorecard and how the call has moved.A free account gets it on three stocks you pick, plus three long research reports a month.

What would change it

Sources

Any one could move it to Keep

Next report

  • Shrinking

    sales

Compared with the S&P 500

  • 8 points

    worse in one day

  • 18 points

    worse in five trading days

+34.1% in a year

Earnings report

The news behind our call

written Oct 6, 10:32 AM ETOct 6, 10:32 AM ET · 20 articles · 12 sources
  • Leerink downgraded Bristol-Myers Squibb, citing concerns about key late-stage drugs and future patent expirations.

  • Bristol-Myers Squibb is expected to increase 2026 earnings.

  • Bristol-Myers Squibb combines strong profitability with an attractive valuation.

What changed

From Yahoo Finance, NIKE, Inc. via Yahoo Finance, Oracle Corporation via Seeking Alpha and 5 more
  1. A 72-year-old with $500,000 in PepsiCo, Nike and Bristol Myers Squibb Collects $1,729 a month in dividends. How Safe is each Check?

    Yesterday

  2. SA analyst upgrades/downgrades: META, UBER, EVGO, ORCL

    Yesterday

  3. Bristol Myers Squibb (BMY) reports 56 week Pediatric Phase 3 Camzyos data

    Monday

  4. Bristol-Myers Squibb says Camzyos shows Sustained Efficacy in Phase 3 Pediatric Trial

    Friday

  5. 3 High-Yield Healthcare stocks to buy with $1,000 and hold through any market

    Friday

  6. Bristol Myers Squibb (BMY) expands Neuroscience push with Multi year AI Alliance

    Friday

  7. Bristol Myers Squibb (BMY) wins FDA approval, is the rally already priced in?

    Nov 5

  8. Why Tempus AI stock is up 8.7% and what's next

    Nov 3

Overview

In plain numbers

  • Revenue grew 4.2% from a year earlier, to $50.0B in the last twelve months.
  • It keeps 32 cents of every revenue dollar as operating profit, up from 18 cents in FY 2021.
  • It turned 18.6% of revenue into free cash flow: $9.3B in the last twelve months.
  • It owes $44.8B and holds $13.0B in cash and investments, so net debt is $31.9B.

Key figures

Revenue (TTM)
$50.0B
Revenue growth, 1 year
+4.2%
Net income
$9.2B
EPS (diluted)
$4.51
Gross margin
70.5%
Operating margin
32.4%
Return on equity
44.0%
Return on capital
23.6%
Debt / equity
1.91
Current ratio
1.59
Dividend yield
4.03%
Buyback yield
-0.48%

Key facts

Company value
$127B
Price / last year's earnings
16.9×
Today's range
62.4664.12
Past year's range
43.8467.39
Yesterday's close
$62.91
Swings vs the market
0.2×smaller
Dividend yield
4.03%$2.52 a year

Compare BMY with

After hours

That's a wrap.

17hrs23min37sec

Market opens Friday, Nov 13 at 9:30 AM ET